Hormonal alterations in heart failure: anabolic impairment in chronic heart failure - diagnostic, prognostic and therapeutic issues.
暂无分享,去创建一个
[1] R. Granata,et al. Cardiovascular Issues in Endocrinology , 2014 .
[2] R. Napoli,et al. Growth hormone replacement delays the progression of chronic heart failure combined with growth hormone deficiency: an extension of a randomized controlled single-blind study. , 2013, JACC. Heart failure.
[3] R. Kloner,et al. Testosterone and the Cardiovascular System: A Comprehensive Review of the Basic Science Literature , 2013, Journal of the American Heart Association.
[4] Daniel B Mark,et al. Thyroid function in heart failure and impact on mortality. , 2013, JACC. Heart failure.
[5] C. Lang,et al. The effect of metformin on insulin resistance and exercise parameters in patients with heart failure , 2012, European journal of heart failure.
[6] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[7] P. Netti,et al. Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model , 2012, Diabetes.
[8] A. Cohen-Solal,et al. Trends in death attributed to heart failure over the past two decades in Europe , 2012, European journal of heart failure.
[9] D. Mozaffarian,et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.
[10] W. März,et al. Low free testosterone is associated with heart failure mortality in older men referred for coronary angiography , 2011, European journal of heart failure.
[11] Takeshi Kimura,et al. Insulin‐like growth factor axis (insulin‐like growth factor‐I/insulin‐like growth factor‐binding protein‐3) as a prognostic predictor of heart failure: association with adiponectin , 2010, European journal of heart failure.
[12] P. Ponikowski,et al. Deficiencies in circulating testosterone and dehydroepiandrosterone sulphate, and depression in men with systolic chronic heart failure , 2010, European journal of heart failure.
[13] H. Völzke,et al. Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. , 2010, European heart journal.
[14] P. Hildebrandt,et al. Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[15] Minoru Horie,et al. Serum Cortisol as a Useful Predictor of Cardiac Events in Patients With Chronic Heart Failure: The Impact of Oxidative Stress , 2009, Circulation. Heart failure.
[16] F. Iellamo,et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. , 2009, Journal of the American College of Cardiology.
[17] L. Saccá,et al. Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction. , 2009, The Journal of clinical endocrinology and metabolism.
[18] L. Saccá. Heart failure as a multiple hormonal deficiency syndrome. , 2009, Circulation. Heart failure.
[19] A. L'Abbate,et al. Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. , 2008, The Journal of clinical endocrinology and metabolism.
[20] P. Komesaroff. Unravelling the enigma of dehydroepiandrosterone: moving forward step by step. , 2008, Endocrinology.
[21] A. El-Menyar. Cytokines and myocardial dysfunction: state of the art. , 2008, Journal of cardiac failure.
[22] M. Dowsett,et al. Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study , 2007, Circulation.
[23] A. Hoes,et al. Clinical epidemiology of heart failure , 2007, Heart.
[24] D. Bonaduce,et al. NT-proBNP, IGF-I and survival in patients with chronic heart failure. , 2007, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[25] A. Araujo,et al. Sex steroids and all-cause and cause-specific mortality in men. , 2007, Archives of internal medicine.
[26] Stefan Störk,et al. Complementary and Incremental Mortality Risk Prediction by Cortisol and Aldosterone in Chronic Heart Failure , 2007, Circulation.
[27] D. Pennell,et al. Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[28] K. Channer,et al. The effect of testosterone on insulin sensitivity in men with heart failure , 2007, European journal of heart failure.
[29] P. Ponikowski,et al. Anabolic Deficiency in Men With Chronic Heart Failure: Prevalence and Detrimental Impact on Survival , 2006, Circulation.
[30] J. Kaufman,et al. The decline of androgen levels in elderly men and its clinical and therapeutic implications. , 2005, Endocrine reviews.
[31] P. Ponikowski,et al. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. , 2005, Journal of the American College of Cardiology.
[32] E. Ingelsson,et al. Insulin resistance and risk of congestive heart failure. , 2005, JAMA.
[33] Douglas L Mann,et al. Mechanisms and models in heart failure: the biomechanical model and beyond. , 2005, Circulation.
[34] J. Funder. RALES, EPHESUS and redox , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[35] K. Channer,et al. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. , 2004, The Journal of clinical endocrinology and metabolism.
[36] R. Jones,et al. Testosterone treatment for men with chronic heart failure , 2004, Heart.
[37] Ralph D'Agostino,et al. Serum Insulin-like Growth Factor I and Risk for Heart Failure in Elderly Individuals without a Previous Myocardial Infarction: The Framingham Heart Study , 2003, Annals of Internal Medicine.
[38] R. Napoli,et al. Acute effects of growth hormone on vascular function in human subjects. , 2003, The Journal of clinical endocrinology and metabolism.
[39] A. L'Abbate,et al. Low-T3 Syndrome: A Strong Prognostic Predictor of Death in Patients With Heart Disease , 2003, Circulation.
[40] P. Sönksen,et al. The role of the growth hormone–insulin‐like growth factor axis in glucose homeostasis , 2003, Diabetic medicine : a journal of the British Diabetic Association.
[41] R. Napoli,et al. Supraphysiological doses of GH induce rapid changes in cardiac morphology and function. , 2002, The Journal of clinical endocrinology and metabolism.
[42] R. Dietz,et al. Growth Hormone Treatment in Dilated Cardiomyopathy , 2001, Journal of cardiac surgery.
[43] B. Walker,et al. Glucocorticoids and insulin resistance: old hormones, new targets. , 1999, Clinical science.
[44] P. Poole‐Wilson,et al. Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. , 1998, Journal of the American College of Cardiology.
[45] B. Biondi,et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. , 1996, The New England journal of medicine.
[46] P. Douglas,et al. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. , 1996, Circulation.
[47] A. Cittadini,et al. Growth hormone and the heart. , 1994, Endocrine reviews.
[48] B. Trimarco,et al. Acute noradrenergic activation induces insulin resistance in human skeletal muscle. , 1994, The American journal of physiology.
[49] B. Bengtsson,et al. Premature mortality due to cardiovascular disease in hypopituitarism , 1990, The Lancet.
[50] E. Vittinghoff,et al. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. , 2008, Journal of the American College of Cardiology.
[51] P. Chanson,et al. Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.
[52] J. Mckinlay,et al. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study. , 2001, American journal of epidemiology.
[53] C. Edwards,et al. Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. , 1988, Lancet.